Diseases such as systematic lupus erythematosus (SLE) and rheumatoid arthritis (RA) may present early (patients aged in their 30s and 40s) or have a late onset (age of 55 years and older).
Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...
Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...
A clear diagnosis can help you to address symptoms and possibly slow disease progression. Inflammatory arthritis like psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis are treated ...
These are the excerpts from an interview conducted with DR. Harindu Wijesinghe (MBBS, MD, MRCP), Consultant Rheumatologist and Specialist in Sports ...
Background Despite treatment according to the current management recommendations, a significant proportion of patients with rheumatoid arthritis (RA) remain symptomatic. These patients can be ...
Neck arthritis (also known as neck osteoarthritis or cervical spondylosis) is the degeneration of the joints, bones, and discs of the cervical spine of the neck. Neck arthritis is a common condition, ...
TNF is a key mediator in autoimmune diseases and during the last couple of decades several biologic drugs have delivered new therapeutic options for patients suffering from chronic autoimmune diseases ...